Liver Cancer | Tumor

Patients with HCC Positively Respond to Opdivo with Yervoy When Nexavar Was Not an Option

November 2nd 2020, 10:00pm

Article

Results of this trial led to an accelerated FDA approval of Opdivo (nivolumab) and Yervoy (ipilimumab) in March to treat this specific patient population.

Patients with Unresectable HCC Lived Longer When Given Hepatic Arterial Infusion Chemotherapy Versus Standard of Care

October 6th 2020, 1:00pm

Article

Overall survival was better with hepatic arterial infusion chemotherapy compared with transarterial chemoembolization, according to phase 3 study findings.

Younger Adults, Women with Cancer Respond Less Well to Immunotherapy with Checkpoint Inhibitors

September 16th 2020, 1:00pm

Article

Younger and female patients with a variety of cancer types tend to have strong immune systems that naturally fight an array of cancer cells. The tumor cells the immune system doesn’t destroy are the most evasive, both to the immune system and medications that boost its activity, and this makes checkpoint inhibitor immunotherapy less effective in this population.

Two-Drug Combination Could Provide Benefits for Cholangiocarcinoma Subset

August 25th 2020, 1:00pm

Article

At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

Can Collaboration Help Find A Cure for Cholangiocarcinoma?

August 22nd 2020, 2:00pm

Article

Could paradigm shifts in cancer research help find a cure for cholangiocarcinoma? Experts discuss.

Uneven Access to Preventive Medicine Could Explain Rising Racial Inequity in Liver Cancer Death Rate

August 21st 2020, 9:00pm

Article

After lifesaving medicine became available to treat hepatitis C virus, a risk factor for liver cancer, racial inequities in the death rate from the malignancy began a steady upward climb.

Ongoing Study May Identify Genetic Factors That Predict Risk of Cholangiocarcinoma

July 29th 2020, 1:00am

Article

The results of an ongoing study designed to reveal genetic characteristics linked with the development of cholangiocarcinoma could pave the way for more accurate prognoses, as well as new treatments.

Numerous Quality-of-Life Disturbances Affect Patients with Cholangiocarcinoma, Survey Finds

July 27th 2020, 10:36pm

Article

A survey administered by pharmaceutical company Incyte and the nonprofit Cholangiocarcinoma Foundation found that patients with bile duct cancer face more than a dozen symptoms or treatment-related side effects that negatively affect their daily lives.

Committed to Change: Blue Faery's Fight Against Liver Cancer

July 20th 2020, 9:54pm

Article

After losing the sister she raised to an aggressive type of liver cancer, one woman has devoted herself to stamping out the disease.

Justice Ruth Bader Ginsburg Receiving Treatment for Cancer Recurrence

July 17th 2020, 10:22pm

Article

U.S. Supreme Court Justice Ruth Bader Ginsburg, 87, has announced that she is currently undergoing chemotherapy for a cancer recurrence.

x